Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Entinostat and Aldesleukin in Metastatic Renal Cell Carcinoma
NCT01038778Phase 2Active, not recruiting
- Sponsor
- National Cancer Institute
- Start
- Oct 2009
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of entinostat in renal cell carcinoma (RCC), sponsored by National Cancer Institute. Started Oct 2009; status: active, not recruiting.
02
Drugs
entinostat
03
Conditions
renal cell carcinoma (RCC)
Beyond the preview
Go deeper on NCT01038778.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01038778.